Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Oslo | OTHER |
Not provided
Not provided
Not provided
Not provided
To describe the broad spectrum of Bipolar Disorder patients admitted to out-patient and in-patient psychiatric departments in Norway. Include all admitted Bipolar patients both with and without co-morbid disorders.
Norway is both social, genetically and culturally a homogeneous society. The health service is public and has a nearly total responsibility for psychiatric care in given catchment areas. This provides excellent opportunities to describe the frequencies and patterns of the broad spectrum of bipolar illness, including co-morbid substance use disorders, to follow the patients for several years and to do molecular genetic mapping.
Methods: Participating centers consist of outpatient clinics and hospital departments from different parts of Norway and one third-line clinic with referrals from all over Norway. Specifically trained clinicians in each center include bipolar patients systematically and perform the patient evaluation as part of their clinical duties. In addition, CT or MRI scans and EEG are performed and blood samples are collected for clinical chemistry screening and for DNA sampling.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Study group | RCT | ||
| Control group | RCT |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Difference in remission | Clinical Interview. Difference (MADRES) in remission between the study and control group. | 15 years |
| Difference in response | Clinical Interview. Difference (MADRS) in response between the study and control group. | 15 years |
| Measure | Description | Time Frame |
|---|---|---|
| GAF | Clinical Interview. Global Assessment of Function | 15 years |
| Current and concomitant medication | Clinical Interview. | 1 year |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Secondary care clinics
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Arne Vaaler, PhD MD | Contact | +47 92090415 | arne.e.vaaler@ntnu.no | |
| Gunnar Morken, PhD MD | Contact | +47 72823034 | gunnar.morken@ntnu.no |
| Name | Affiliation | Role |
|---|---|---|
| Gunnar Morken, PhD MD | Norwegian University of Science and Technology | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Medical Faculty, Norwegian University of Science And Technology | Recruiting | Trondheim | 7441 | Norway |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 20178636 | Background | Kessler U, Vaaler AE, Schoyen H, Oedegaard KJ, Bergsholm P, Andreassen OA, Malt UF, Morken G. The study protocol of the Norwegian randomized controlled trial of electroconvulsive therapy in treatment resistant depression in bipolar disorder. BMC Psychiatry. 2010 Feb 23;10:16. doi: 10.1186/1471-244X-10-16. | |
| 23557429 | Background |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001714 | Bipolar Disorder |
| ID | Term |
|---|---|
| D000068105 | Bipolar and Related Disorders |
| D019964 | Mood Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Blood samples
| SF36 | Clinical Interview. | 1 year |
| MADRS | Clinical Interview. | 1 year |
| IDS Inventory of depressive sympthoms | Clinical Interview. | 1 year |
| CGI-BP Clinical Global Index - Bipolar | Clinical Interview. | 1 year |
| PGI-1 (Patient global index) | Clinical Interview. | 1 year |
| YMRS (Young mania rating scale) | Clinical Interview. | 1 year |
| MSIF (Quality of life scale) | Clinical Interview. | 1 year |
| MMS (Minimal mental scale) | Clinical Interview. | 1 year |
| EMQ (Neuropsychology) | Clinical Interview. | 1 year |
| UKU (Medication side effects) | Clinical Interview. | 1 year |
| SAE-form (Serious adverse events) | Clinical Interview. | 1 year |
| Cytokines | Laboratory | 1 year |
| Cortisol | Laboratory | 1 year |
| Substance used | Laboratory, Urine | 1 st week |
| Compliance (medication) | Clinical interview | 1 st year |
| TEMPS-A (Temperament) | Clinical interview | Week 26 |
| Migraine (Clinical interview) | Clinical interview | Week 1 and week 26 |
| Kessler U, Schoeyen HK, Andreassen OA, Eide GE, Hammar A, Malt UF, Oedegaard KJ, Morken G, Sundet K, Vaaler AE. Neurocognitive profiles in treatment-resistant bipolar I and bipolar II disorder depression. BMC Psychiatry. 2013 Apr 4;13:105. doi: 10.1186/1471-244X-13-105. |
| 25470096 | Background | Kessler U, Schoeyen HK, Andreassen OA, Eide GE, Malt UF, Oedegaard KJ, Morken G, Sundet K, Vaaler AE. The effect of electroconvulsive therapy on neurocognitive function in treatment-resistant bipolar disorder depression. J Clin Psychiatry. 2014 Nov;75(11):e1306-13. doi: 10.4088/JCP.13m08960. |
| 25219389 | Background | Schoeyen HK, Kessler U, Andreassen OA, Auestad BH, Bergsholm P, Malt UF, Morken G, Oedegaard KJ, Vaaler A. Treatment-resistant bipolar depression: a randomized controlled trial of electroconvulsive therapy versus algorithm-based pharmacological treatment. Am J Psychiatry. 2015 Jan;172(1):41-51. doi: 10.1176/appi.ajp.2014.13111517. Epub 2014 Oct 31. |
| 29267990 | Background | Bjoerke-Bertheussen J, Schoeyen H, Andreassen OA, Malt UF, Oedegaard KJ, Morken G, Sundet K, Vaaler AE, Auestad B, Kessler U. Right unilateral electroconvulsive therapy does not cause more cognitive impairment than pharmacologic treatment in treatment-resistant bipolar depression: A 6-month randomized controlled trial follow-up study. Bipolar Disord. 2018 Sep;20(6):531-538. doi: 10.1111/bdi.12594. Epub 2017 Dec 21. |
| 33287748 | Derived | Drange OK, Saether SG, Finseth PI, Morken G, Vaaler AE, Arntsen V, Henning O, Andreassen OA, Elvsashagen T, Malt UF, Boen E. Differences in course of illness between patients with bipolar II disorder with and without epileptiform discharges or other sharp activity on electroencephalograms: a cross-sectional study. BMC Psychiatry. 2020 Dec 7;20(1):582. doi: 10.1186/s12888-020-02968-4. |
| 30198055 | Derived | Drange OK, Vaaler AE, Morken G, Andreassen OA, Malt UF, Finseth PI. Clinical characteristics of patients with bipolar disorder and premorbid traumatic brain injury: a cross-sectional study. Int J Bipolar Disord. 2018 Sep 10;6(1):19. doi: 10.1186/s40345-018-0128-6. |